Protagonist Therapeutics to Host Investor Conference Call and Webcast to Discuss Updated Phase 2 Rusfertide Results in Polycythemia Vera as Presented at EHA 2021

Press/Media

Period7 Jun 2021

Media coverage

1

Media coverage